63.39
0.18 (0.28%)
| Penutupan Terdahulu | 63.21 |
| Buka | 63.35 |
| Jumlah Dagangan | 2,224,424 |
| Purata Dagangan (3B) | 2,421,864 |
| Modal Pasaran | 14,224,081,920 |
| Harga / Pendapatan (P/E TTM) | 20.06 |
| Harga / Pendapatan (P/E Ke hadapan) | 15.17 |
| Harga / Jualan (P/S) | 3.75 |
| Harga / Buku (P/B) | 3.04 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Apr 2025 - 5 May 2025 |
| Margin Keuntungan | 18.42% |
| Margin Operasi (TTM) | 22.87% |
| EPS Cair (TTM) | 3.16 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 0.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -18.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 53.22% |
| Nisbah Semasa (MRQ) | 3.48 |
| Aliran Tunai Operasi (OCF TTM) | 1.25 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 902.83 M |
| Pulangan Atas Aset (ROA TTM) | 7.10% |
| Pulangan Atas Ekuiti (ROE TTM) | 15.78% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | Hologic, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | 3.0 |
| Volatiliti Harga | 5.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | 1.70 |
|
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 1.13% |
| % Dimiliki oleh Institusi | 104.90% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 90.00 (Raymond James, 41.98%) | Beli |
| 90.00 (Needham, 41.98%) | Pegang | |
| Median | 83.00 (30.94%) | |
| Rendah | 70.00 (Citigroup, 10.43%) | Pegang |
| Purata | 81.13 (27.99%) | |
| Jumlah | 2 Beli, 6 Pegang | |
| Harga Purata @ Panggilan | 66.45 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 04 Mar 2025 | 70.00 (10.43%) | Pegang | 62.30 |
| Evercore ISI Group | 06 Feb 2025 | 73.00 (15.16%) | Pegang | 65.45 |
| Leerink Partners | 06 Feb 2025 | 75.00 (18.32%) | Pegang | 65.45 |
| RBC Capital | 06 Feb 2025 | 85.00 (34.09%) | Pegang | 65.45 |
| Raymond James | 06 Feb 2025 | 90.00 (41.98%) | Beli | 65.45 |
| Stephens & Co. | 06 Feb 2025 | 84.00 (32.51%) | Beli | 65.45 |
| Needham | 03 Feb 2025 | 90.00 (41.98%) | Pegang | 71.72 |
| 13 Jan 2025 | 90.00 (41.98%) | Beli | 70.29 | |
| Morgan Stanley | 13 Jan 2025 | 82.00 (29.36%) | Pegang | 70.29 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |